AlphaHubby Profile Banner
Alexander Henke Profile
Alexander Henke

@AlphaHubby

Followers
218
Following
1K
Media
71
Statuses
1K

Biologist and ambitious retail trader. DISCLAIMER: No investment advice. Just my personal opinion. Do your own research! Assume, I could have a position.

Germany
Joined January 2022
Don't wanna be here? Send us removal request.
@AlphaHubby
Alexander Henke
11 months
1/# I'm long Corcept Therapeutics. $CORT is a commercial stage biotech with a positive cash balance and cash flow so far in 2024. In Q4 / 2024, they expect the read outs of two pivotal phase 3 trials. And it appears others are piling in as well.
1
0
0
@AlphaHubby
Alexander Henke
3 months
RT @Psyched_Alpha: Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle. “Rest assured, we’ve got something pretty special here”, $CMPS….
0
10
0
@grok
Grok
18 days
What do you want to know?.
928
641
4K
@AlphaHubby
Alexander Henke
5 months
$CORT. Called it, albeit with a little delay of the readout of the ROSELLA trial. Press release today on their positive results with a significant overall survival advantage:.
ir.corcept.com
Relacorilant plus nab-paclitaxel improved progression-free and overall survival and did not increase side effect burden Results will support a New Drug Application (NDA) in the United States and a...
@AlphaHubby
Alexander Henke
11 months
1/# I'm long Corcept Therapeutics. $CORT is a commercial stage biotech with a positive cash balance and cash flow so far in 2024. In Q4 / 2024, they expect the read outs of two pivotal phase 3 trials. And it appears others are piling in as well.
1
0
2
@AlphaHubby
Alexander Henke
6 months
RT @RayDalio: How Countries Go Broke: The Big Cycle. As you probably know by now, I'm in a stage of life that has led me to want to pass al….
0
388
0
@AlphaHubby
Alexander Henke
6 months
$CMPS has been on my watch list for a year now. Time to go long for their Ph3 read out in Q2/2025. .
@melissaarcherr
Melissa archer
6 months
Good morning, my second stock to buy today is $CMPS. Buy at current price $3.85. COMP360 shows promise in treating refractory depression and PTSD, with significant clinical trial results and potential long-term economic benefits.
Tweet media one
0
0
1
@AlphaHubby
Alexander Henke
6 months
Long $CORT. Yesterday's earnings call did not disappoint! Ph3 ROSELLA trial has a high chance of being positive = CATALYST for more upside. # of events triggered analysis! I expect a press release in 2-8 weeks from CORT
Tweet media one
0
0
0
@AlphaHubby
Alexander Henke
6 months
After $RILY's unexpected jump up >$6, I reentered into a short position. RILY is a donut !!!!!!!!!!.
@AlderLaneEggs
Marc Cohodes
6 months
I wonder what Nomura heard on its Bi-Weekly Litigation and Investigation call that made them walk? $RILY. When is enough enough ⁦@SECGov@business
Tweet media one
1
0
1
@AlphaHubby
Alexander Henke
6 months
A very worthwhile tweet by @TheShortBear based on overvaluation in certain sectors.
@TheShortBear
THE SHORT BEAR
7 months
Cracks forming. A few events that made my riskometer flash:. • $COIN breaking down its lows anchored VWAP. • $MSTR breaking down its multimonth trend line support. • $PLTR big distribution day and failing to hold 9ema. • $MSFT breaking its 200ema/ma. • $OKLO parabolic and.
0
0
0
@AlphaHubby
Alexander Henke
6 months
The previous German government coalition had the Green Party as toxic element for the national economy - with an author of children's books as minister for economy, subject he had no clue about.
0
0
0
@AlphaHubby
Alexander Henke
6 months
Germany: the elections clearly show that the conservatives (CDU/CSU) won but they still need a coalition partner. Most likely the labor party (SPD). Most likely this coalition will be more economy friendly than the previous government coalition.
1
0
0
@AlphaHubby
Alexander Henke
7 months
industrially produced diamonds cost a fraction of natural diamonds and come without any ethical problems. The short $SIG makes perfect sense to me.
@StockJabber
Edwin Dorsey
7 months
Short $SIG and the entire diamond industry is my favorite idea for 2025. Sometimes the best ideas are obvious
Tweet media one
Tweet media two
0
0
1
@AlphaHubby
Alexander Henke
7 months
RT @StockJabber: Starting today, @FOIAsearch lets any investor search all FOIA requests filed with the SEC. This valuable information helps….
0
87
0
@AlphaHubby
Alexander Henke
7 months
A nice tool and well explained by Edwin from @StockJabber.
@StockJabber
Edwin Dorsey
7 months
Starting today, @FOIAsearch lets any investor search all FOIA requests filed with the SEC. This valuable information helps investors detect undisclosed SEC investigations and much more. Every year, the SEC spends ~$14 million responding to 10,000+ FOIA requests, which gives some
0
0
1
@AlphaHubby
Alexander Henke
7 months
RT @BraVoCycles: Bears must love SPX seasonality for the next 30-40 days.
Tweet media one
0
72
0
@AlphaHubby
Alexander Henke
7 months
RT @AntonKreil: Ultra High Net Worth Individual = UHNWI .Classed as Net Worth of $30mln USD or more. UHNWI in China = 74,000 .UHNWI in U.S….
0
28
0
@AlphaHubby
Alexander Henke
7 months
$CORT great news today: massive increase of price target.
@Quantumup1
quantumup
7 months
Canaccord Genuity⬆️the PT on $CORT to $130 was $78 and reiterated at a Buy rating after they recently had the opportunity to catch up with the management team at Corcept. Canaccord said it sees strong likelihood of relacorilant approval for Cushing's in 2025, they believe Ph3.
0
0
0
@AlphaHubby
Alexander Henke
7 months
$ENVX and $TSLA.If this were true. .
@bleacherbum23
Football Guy's Guy
7 months
$TSLA $ENVX well this is a first from Google’s AI generator. My jaw is on the floor. @eenLien @RocketPenguin75 @Foldnow1984 @2percentisfair @mcinnes_danny @amitisinvesting @jmalchow @AlderLaneEggs
Tweet media one
0
0
9
@AlphaHubby
Alexander Henke
8 months
Funny, I was actually thinking about to go short $PLTR anyway. 🤣.
@unusual_whales
unusual_whales
8 months
Oh, no. $PLTR
Tweet media one
0
0
0
@AlphaHubby
Alexander Henke
8 months
I agree and remain long $CORT.
@i3_invest
Guilherme Tavares
8 months
We remain bullish $CORT. CORT is experiencing strong growth while remaining reasonably priced. Our cumulative return for this stock since portfolio's inception is 80% (in less than 8 months).
0
0
0
@AlphaHubby
Alexander Henke
8 months
RT @NateHindenburg: $RENB announces an all-stock deal to acquire a different bioscam that traded with a $4m market cap a week ago. https:/….
Tweet card summary image
globenewswire.com
- Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple cancer...
0
8
0
@AlphaHubby
Alexander Henke
8 months
RT @unusual_whales: The JPMorgan, $JPM, healthcare conference happened on the 13-16th. What are the highlights?. Join experts, sponsored….
0
11
0